Source comparison
Ipamorelin Cycle Length: Protocol Comparison
The following table summarizes the most commonly used ipamorelin cycle protocols in published research, comparing cycle duration, dosing frequency, washout requirements, and the contexts in which each is most suitable. | Protocol Type | Cycle Length | Typical
This comparison does not assign a generated winner or score.
- The following table summarizes the most commonly used ipamorelin cycle protocols in published research, comparing cycle duration, dosing frequency, washout requirements, and the contexts in which each is most suitable.
- | Protocol Type | Cycle Length | Typical Dose & Frequency | Washout Duration | Best Application | Receptor Preservation | Professional Assessment ||—|—|—|—|—|—|| Short Cycle | 8 weeks | 200–300 mcg, 2x daily | 4 weeks | Acute metabolic studies, rapid turnover research | High. Minimal desensitization observed | Ideal for studies requiring multiple observation windows per year; sufficient for body composition endpoints || Standard Cycle | 12 weeks | 250–300 mcg, 2–3x daily | 6 weeks | Most general research applications; metabolic, aging, tissue repair | Moderate. Desensitization begins week 10–12 | Most commonly cited in peer-reviewed literature; balances efficacy and recovery time || Extended Cycle | 16 weeks | 200–300 mcg, 2x daily | 8 weeks | Long-term tissue remodeling, collagen synthesis studies | Moderate to Low. Significant decline after week 14 | Maximum duration before washout is mandatory; extending beyond 16 weeks negates benefit || Intermittent Cycle | 12 weeks (5-on-2-off) |
- The bottom line: ipamorelin cycle length should be chosen based on research endpoints and timeline. If the study measures outcomes that require sustained GH elevation for 12+ weeks. Such as bone density changes or significant lean mass accretion. A 12–16 week cycle is necessary. If the study tracks acute metabolic markers like fasting glucose or lipid oxidation, an 8-week cycle with shorter washout allows more experimental iterations per year. The worst approach is continuous use without breaks. It guarantees diminishing efficacy and wastes both time and compound.